Grants and Contributions

• The CIHR HIV/AIDS Research Initiative, which is responsible for the management and oversight of the research components of the Federal Initiative to Address HIV/AIDS in Canada, will provide funding for applications that have a primary focus on HIV/AIDS and/or other sexually-transmitted and blood-borne infections (STBBIs) across all CIHR Research Themes (i.e., biomedical research, clinical research, health services research and social, cultural, environmental and population health research).
• Research that focuses on key populations identified by the Federal Initiative to Address HIV/AIDS in Canada is highly encouraged. Key populations include: First Nations, Inuit and Métis peoples; gay men and other men who have sex with men; women; youth at risk; injection drug users; prison inmates; people living with HIV/AIDS; and people from countries where HIV is endemic.

This funding opportunity is expected to:

• Advance knowledge through the analysis of existing cohorts, data platforms and/or administrative datasets specific to one of the research areas above.

The Operating Grant: Methamphetamine and related psychostimulant use is expected to:

• Generate new knowledge around prevalence, incidence, and distribution of methamphetamine use in Canada
• Increase the uptake and application of synthesized knowledge in evidence-based decision-making, health care and/or health services policy and practice in this space
• Support partnerships between researchers and knowledge users to rapidly inform policies related to prevention, harm reduction, and treatment of methamphetamine use
• Address the pressing intervention-related evidence needs of knowledge users in this space
• Encourage implementation science approaches that consider sub-populations and/or the biological and social determinants of methamphetamine use

The objective of this funding opportunity is to catalyze and support research efforts of Canadian researchers to use the available CLSA data in order to better understand how (individually and in combination) the biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact in both maintaining health and in the development of disease and disability as people age.

• The Institute of Neurosciences, Mental Health and Addiction (INMHA) will fund an application that is determined to be relevant to the mandate and research priority areas of CIHR-INMHA
o The Institute of Neurosciences, Mental Health and Addiction supports (INMHA) research to enhance mental health, neurological health, vision, hearing, and cognitive functioning and to reduce the burden of related disorders through prevention strategies, screening, diagnosis, treatment, support systems, and palliation.

• The Canadian Epigenetics, Environment and Health Research Consortium (CEEHRC) will fund an application that is determined to be relevant to the key research needs and objectives of CEEHRC
o CEEHRC supports leading edge research on the role of DNA and environment interactions in human health and disease and translating epigenetic discoveries into better clinical care and outcomes for patients.

• This prize was established to recognize the excellence of cancer research being conducted in Canada. This prize will be given annually to Early Career Investigators ranking high in the Project Scheme competitions that fall within the Institute of Cancer Research (ICR) mandate:

o ICR has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.

The “Catalyst Grant: Addressing Musculoskeletal Conditions and Arthritis in Canadians” is expected to:

• Support original, high quality projects that have the potential to generate innovative research, research tools, techniques, devices, inventions, or methods that will translate into a clinical or health services improvement for Canadians within 5-7 years;
• Facilitate team formation and build patient-oriented research capacity by encouraging partnerships amongst patients, patient communities, patient organizations and health charities, researchers, health care professionals and health system decision makers or policy makers;
• Generate preliminary observations, data or knowledge to stimulate research in areas where there is a substantial burden of disease in musculoskeletal conditions and arthritis in Canada, as identified by the respective communities.

The Understanding Disease Prevention and Risk Factor Modification Catalyst Grants are expected to:

• increase our understanding of factors that enable individuals to adopt or overlook known disease risk modification strategies;
• expand the evidence and further understanding that can lead to future intervention studies in prevention; and
• develop a knowledge base upon which to nuance evidence-based policy to improve the prevention of manageable diseases.

• The CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) will provide funding for an application determined to be relevant to the broad INMD mandate as described below:
o CIHR-INMD supports research to enhance health in relation to diet, digestion, excretion, and metabolism; and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions and problems associated with hormone, digestive system, kidney, and liver.
• These grants afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.